HS 2920-21-00-00 – Dimethyl phosphite
Tariff data as of T2026-2, effective Sept 1, 2026, last verified Oct 21, 2026
Esters of other inorganic acids of non-metals (excluding esters of hydrogen halides) and their salts; their halogenated, sulphonated, nitrated or nitrosated derivatives. › Dimethyl phosphite › Dimethyl phosphite
- MFN duty rate
- Free
- GST
- 5%
- Unit of measure
- KGM
Dimethyl phosphite
Estimate duty & taxes · Get classification help
Preferential tariff rates
- CETA: Free
- Ukraine: Free
- CPTPP: Free
- Jordan (JT): Free
- Chile: Free
- CPTPP – United Kingdom (CPUKT): Free
- Panama (PAT): Free
- Peru: Free
- GPT: Free
- UST/CUSMA (US): Free
- Iceland: Free
- Costa Rica (CRT): Free
- Honduras (HNT): Free
- Switzerland–Liechtenstein (SLT): Free
- Israel (CIAT): Free
- Commonwealth Caribbean Countries Tariff (CCCT): Free
- Colombia: Free
- MXT/CUSMA (Mexico): Free
- Norway (NT): Free
- LDCT: Free
- Korea: Free
- UK: Free
Preference requires qualifying origin and origin proof or certification.
Frequently asked questions
What is the MFN duty on Dimethyl phosphite (HS 2920-21-00-00)?
The T2026-2 MFN rate for tariff item 2920.21.00 is Free. Specific or compound rates require manual calculation. Classification and origin must be verified with CBSA.
What is the duty on HS 2920-21-00-00 from the US?
Qualifying US-origin goods with origin proof use UST/CUSMA at Free. This item is not on any US surtax schedule in force in TariffPlus surtax data (checked against CBSA). GST/HST and any applicable personal-import provincial tax are additional.
Which trade agreement rates apply to HS 2920-21-00-00?
CETA: Free; Ukraine: Free; CPTPP: Free; Jordan (JT): Free; Chile: Free; CPTPP – United Kingdom (CPUKT): Free; Panama (PAT): Free; Peru: Free; GPT: Free; UST/CUSMA (US): Free; Iceland: Free; Costa Rica (CRT): Free; Honduras (HNT): Free; Switzerland–Liechtenstein (SLT): Free; Israel (CIAT): Free; Commonwealth Caribbean Countries Tariff (CCCT): Free; Colombia: Free; MXT/CUSMA (Mexico): Free; Norway (NT): Free; LDCT: Free; Korea: Free; UK: Free. Preferential treatment requires qualifying origin and certification. Rates are informational; CBSA is authoritative.